Literature DB >> 28384683

Characterizing 18 Years of the Death With Dignity Act in Oregon.

Charles Blanke1,2, Michael LeBlanc2, Dawn Hershman2, Lee Ellis2, Frank Meyskens2.   

Abstract

Importance: Numerous states have pending physician-aided dying (PAD) legislation. Little research has been done regarding use of PAD, or ways to improve the process and/or results.
Objectives: To evaluate results of Oregon PAD, the longest running US program; to disseminate results; and to determine promising PAD research areas. Design, Setting, and Participants: A retrospective observational cohort study of 991 Oregon residents who had prescriptions written as part of the state's Death with Dignity Act. We reviewed publicly available data from Oregon Health Authority reports from 1998 to 2015, and made a supplemental information request to the Oregon Health Authority. Main Outcomes and Measures: Number of deaths from self-administration of lethal medication versus number of prescriptions written.
Results: A total of 1545 prescriptions were written, and 991 patients died by using legally prescribed lethal medication. Of the 991 patients, 509 (51.4%) were men and 482 (48.6%) were women. The median age was 71 years (range, 25-102 years). The number of prescriptions written increased annually (from 24 in 1998 to 218 in 2015), and the percentage of prescription recipients dying by this method per year averaged 64%. Of the 991 patients using lethal self-medication, 762 (77%) recipients had cancer, 79 (8%) had amyotrophic lateral sclerosis, 44 (4.5%) had lung disease, 26 (2.6%) had heart disease, and 9 (0.9%) had HIV. Of 991 patients, 52 (5.3%) were sent for psychiatric evaluation to assess competence. Most (953; 96.6%) patients were white and 865 (90.5%) were in hospice care. Most (118, 92.2%) patients had insurance and 708 (71.9%) had at least some college education. Most (94%) died at home. The estimated median time between medication intake and coma was 5 minutes (range, 1-38 minutes); to death it was 25 minutes (range, 1-6240 minutes). Thirty-three (3.3%) patients had known complications. The most common reasons cited for desiring PAD were activities of daily living were not enjoyable (89.7%) and losses of autonomy (91.6%) and dignity (78.7%); inadequate pain control contributed in 25.2% of cases. Conclusions and Relevance: The number of PAD prescriptions written in Oregon has increased annually since legislation enactment. Patients use PAD for reasons related to quality of life, autonomy, and dignity, and rarely for uncontrolled pain. Many questions remain regarding usage and results, making this area suitable for cancer care delivery research.

Entities:  

Mesh:

Year:  2017        PMID: 28384683      PMCID: PMC5824315          DOI: 10.1001/jamaoncol.2017.0243

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  2 in total

Review 1.  Attitudes and Practices of Euthanasia and Physician-Assisted Suicide in the United States, Canada, and Europe.

Authors:  Ezekiel J Emanuel; Bregje D Onwuteaka-Philipsen; John W Urwin; Joachim Cohen
Journal:  JAMA       Date:  2016-07-05       Impact factor: 56.272

2.  Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial.

Authors:  William Breitbart; Barry Rosenfeld; Christopher Gibson; Hayley Pessin; Shannon Poppito; Christian Nelson; Alexis Tomarken; Anne Kosinski Timm; Amy Berg; Colleen Jacobson; Brooke Sorger; Jennifer Abbey; Megan Olden
Journal:  Psychooncology       Date:  2010-01       Impact factor: 3.894

  2 in total
  9 in total

1.  Missing Source Credit for Figure and Table.

Authors: 
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

2.  Error in Patient Data in Abstract and Text.

Authors: 
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

3.  Characterizing Kaiser Permanente Southern California's Experience With the California End of Life Option Act in the First Year of Implementation.

Authors:  Huong Q Nguyen; Eduard J Gelman; Tracey A Bush; Janet S Lee; Michael H Kanter
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

4.  Trends in Medical Aid in Dying in Oregon and Washington.

Authors:  Luai Al Rabadi; Michael LeBlanc; Taylor Bucy; Lee M Ellis; Dawn L Hershman; Frank L Meyskens; Lynne Taylor; Charles D Blanke
Journal:  JAMA Netw Open       Date:  2019-08-02

Review 5.  Challenges of Survivorship for Older Adults Diagnosed with Cancer.

Authors:  Margaret I Fitch; Irene Nicoll; Lorelei Newton; Fay J Strohschein
Journal:  Curr Oncol Rep       Date:  2022-03-14       Impact factor: 5.945

Review 6.  Talking about the end of life: communication patterns in amyotrophic lateral sclerosis - a scoping review.

Authors:  Anke Erdmann; Celia Spoden; Irene Hirschberg; Gerald Neitzke
Journal:  Palliat Care Soc Pract       Date:  2022-03-15

7.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

8.  Medical Assistance in Dying in patients with advanced cancer and their caregivers: a mixed methods longitudinal study protocol.

Authors:  Madeline Li; Gilla K Shapiro; Roberta Klein; Anne Barbeau; Anne Rydall; Jennifer A H Bell; Rinat Nissim; Sarah Hales; Camilla Zimmermann; Rebecca K S Wong; Gary Rodin
Journal:  BMC Palliat Care       Date:  2021-07-21       Impact factor: 3.234

9.  Palliative sedation and medical assistance in dying: Distinctly different or simply semantics?

Authors:  Reanne Booker; Anne Bruce
Journal:  Nurs Inq       Date:  2019-11-22       Impact factor: 2.658

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.